Research and innovation news

Manchester researchers have found new evidence to suggest that people with rheumatoid arthritis who stop smoking, dramatically reduce their risk of earlier death.

More than 35 patients with rare kidney disorder membranous nephropathy have come together in Manchester for the first ever national forum to find out more about latest research into the condition.

Research led by Rebecca Joseph at the NIHR Manchester Musculoskeletal BRU has found evidence that demonstrates adrenal insufficiency at all levels of glucocorticoid exposure, even low dosage.

Last week the research team at the Kellgren Centre for Rheumatology reached a key milestone in recruiting the 500th patient onto the BILAG Biologics Register study.

Patients with Nephrotic Syndrome (NS), their families and medical staff got together at The Nowgen Centre at CMFT this week to learn more about the condition.

Central Manchester University Hospitals NHS Foundation Trust (CMFT) today announces the creation of a new 10-year strategic property partnership with leading property company Bruntwood.

Up to £5000 per application is up for grabs through the Wellcome Trust Institutional Strategic Support Fund.

It was around twenty years ago when Guy Hill was diagnosed with IgA Nephropathy (IGAN) a form of inflammation in the kidney disease, at the age of 35 years old.